Navigation Links
Quest Diagnostics Commences Tender Offer for Acquisition of Celera
Date:3/28/2011

MADISON, N.J., March 28, 2011 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced today it has commenced a tender offer through its wholly owned subsidiary, Spark Acquisition Corporation, for all of the outstanding shares of common stock (the "Shares") of Celera Corporation (Nasdaq: CRA), one of the world's pioneers in genetic diagnostics discovery and development for $8.00 per share in cash, without interest and less any required withholding taxes.

The tender offer is being made pursuant to an Offer to Purchase, dated March 28, 2011, and in connection with the previously announced Agreement and Plan of Merger, dated March 17, 2011, by and among Quest Diagnostics, Spark Acquisition Corporation and Celera.

The tender offer will expire on April 25, 2011, at 5:00 p.m. New York City time, unless extended in accordance with the Merger Agreement and the applicable rules and regulations of the Securities and Exchange Commission.  Any extension of the tender offer will be followed as promptly as practicable by public announcement thereof, and such announcement will be made no later than 9:00 a.m. New York City time on the next business day after the previously scheduled expiration date.

The tender offer is subject to customary conditions, including the tender of a majority of the outstanding Shares (calculated on a fully-diluted basis), as well as the receipt of certain regulatory approvals and other closing conditions.  The board of directors of each of Quest Diagnostics and Celera have approved the transaction.

Today, Quest Diagnostics will file with the SEC a tender offer statement on Schedule TO, setting forth in detail the terms of the tender offer.  Celera will file tod
'/>"/>

SOURCE Quest Diagnostics Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. SimQuest Develops Worlds First Platform for Open Surgical Simulation
2. Quest Diagnostics Launches National Electronic Health Records Awareness Tour Showcasing Care360 EHR
3. Quest Diagnostics Incorporated Announces Proposed Senior Notes Offering
4. Quest Diagnostics to Acquire Celera, Strengthening Position as Worlds Leading Innovator in Molecular Diagnostics and Development
5. Questcor Pharmaceuticals to Present at the Barclays Capital Global Healthcare Conference
6. CardioGenics Requests Stockholders to Participate in Stockholder Questionnaires
7. Questcor Pharmaceuticals Selects BDO USA as its Auditor
8. Questcor Reports 2010 Financial Results
9. Physicians Who Treat Obesity Question FDA Rejection of Contrave
10. Questcor to Report Fourth Quarter and Full Year 2010 Earnings and Conduct Conference Call on February 23, 2011
11. Quest Diagnostics Announces Pricing in Offering of Common Stock by the Companys Largest Shareholder
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... 2015 Rock Creek Pharmaceuticals, Inc., (NASDAQ: ... inflammatory disease and neurologic disorders, announced today the results ... citrate, the Company,s lead compound. Results from the study ... can significantly inhibit the activation of inflammatory proteins in ... this compound in a Phase 1 clinical trial under ...
(Date:7/1/2015)... , July 1, 2015  BioPharmX Corporation (NYSE MKT: ... underwritten public offering of 3,636,364 shares of its common ... per share. BioPharmX has granted the underwriters a 30-day ... common stock at the public offering price. ... an existing stockholder, has agreed to purchase 1,081,081 shares ...
(Date:6/30/2015)... Scotland , July 1, 2015 ... joins Nu C ana team   ... ProTide technology to develop and commercialise a portfolio of ... Chris McGuigan as Chief Scientific Officer. ... ProTide technology. He is currently Professor of Medicinal Chemistry ...
Breaking Medicine Technology:Rock Creek Pharmaceuticals Reports Human Proof of Principle Study of Lead Compound Demonstrating Inhibition of Inflammatory Markers In White Blood Cells 2Rock Creek Pharmaceuticals Reports Human Proof of Principle Study of Lead Compound Demonstrating Inhibition of Inflammatory Markers In White Blood Cells 3Rock Creek Pharmaceuticals Reports Human Proof of Principle Study of Lead Compound Demonstrating Inhibition of Inflammatory Markers In White Blood Cells 4BioPharmX Corporation Closes Underwritten Public Offering of Common Stock 2BioPharmX Corporation Closes Underwritten Public Offering of Common Stock 3Internationally Renowned Medicinal Chemist Professor Chris McGuigan Appointed as NuCana's Chief Scientific Officer 2Internationally Renowned Medicinal Chemist Professor Chris McGuigan Appointed as NuCana's Chief Scientific Officer 3
... Amgen (Nasdaq: AMGN ), today announced the ... privately held biotechnology company based in Woburn, Mass., with ... a novel investigational oncolytic vaccine in Phase 3 clinical ... melanoma and head and neck cancer. The acquisition was ...
... , a leader in bioinformatics software and knowledge integration, ... license for Pathway Studio ® Enterprise system that ... MedScan® text processing technology for site-wide use. Pathway Studio ... pathways and develop mechanistic rationale for disease based on ...
Cached Medicine Technology:Amgen Completes Acquisition of BioVex 2Amgen Completes Acquisition of BioVex 3Amgen Completes Acquisition of BioVex 4Site-wide License for Ariadne's Pathway Studio Renewed by NCI 2
(Date:7/1/2015)... ... July 01, 2015 , ... During the ... (Manager, National Sales Training and Development) and Chuck Corso (Associate Sales Trainer) participated ... Phoenix, AZ. LTEN brings together learning and development professionals from more than 300 ...
(Date:7/1/2015)... Colorado) , ... - (PRWEB) July 01, 2015 , ... ... a nationwide virtual 5K on August 15-16th (MSG Keys’ birthday) in memory of her ... a highly decorated soldier and recipient of the Bronze Star Medal, died during a ...
(Date:7/1/2015)... ... July 01, 2015 , ... “Well-meaning ... Lisa Stolzenberg, a Professor in FIU’s School of International and Public Affairs. ... years who participated in the National Survey on Drug Use and Health, which ...
(Date:7/1/2015)... NJ (PRWEB) , ... July 01, 2015 , ... Scoliosis is a disorder in which ... National Scoliosis Foundation, it affects 2 to 3 percent of the population, or an estimated ... most often develops in children between the ages of 10 and 15. Most types of ...
(Date:7/1/2015)... Sarasota, FL (PRWEB) , ... July 01, 2015 ... ... providers of premium delicatessen products, is helping families get ready for Independence Day ... to sweet sliders, these easy and versatile options are perfect for any summertime ...
Breaking Medicine News(10 mins):Health News:Mission Pharmacal Company: Alamo Pharma Services' Training Leaders Take Steps to Further Expand Capabilities for Mission Pharmacal and Other Clients 2Health News:Mission Pharmacal Company: Alamo Pharma Services' Training Leaders Take Steps to Further Expand Capabilities for Mission Pharmacal and Other Clients 3Health News:Mission Pharmacal Company: Alamo Pharma Services' Training Leaders Take Steps to Further Expand Capabilities for Mission Pharmacal and Other Clients 4Health News:Wife of Fallen Special Forces Soldier to Host Nationwide ‘Virtual 5K’ for Charity 2Health News:Wife of Fallen Special Forces Soldier to Host Nationwide ‘Virtual 5K’ for Charity 3Health News:Researchers find that medical marijuana laws increase recreational marijuana use among juveniles 2Health News:Scoliosis: A Guide for Parents from Orthopedic Surgeon Dr. Fabien Bitan 2Health News:Scoliosis: A Guide for Parents from Orthopedic Surgeon Dr. Fabien Bitan 3Health News:Scoliosis: A Guide for Parents from Orthopedic Surgeon Dr. Fabien Bitan 4Health News:Boar’s Head Helps Craft a Delicious Independence Day 2Health News:Boar’s Head Helps Craft a Delicious Independence Day 3
... Jan. 20 AXIOM Systems, Inc. (AXIOM), considered the ... release of products and services that assist organizations in the ... extensive testing of internal processes and external trading partner capabilities ... a larger challenge, to test the business impacts inherent in ...
... ... most advanced treatment options with an eye toward aesthetics, limiting visible scarring and focusing on ... ... opened a new office in Staten Island, offering comprehensive foot care with a focus on ...
... , Helping vulnerable children in aftermath of earthquake ... Given the chaos on the ground in Haiti , it ... children. , Because ChildFund does not operate in Haiti ... in Haiti for 30 years. This supports an established ...
... international multi-center clinical trial has found that acyclovir, a drug ... daily to suppress herpes simplex virus-2 (HSV-2), which is the ... risk of HIV transmission when taken by people infected with ... are published in the New England Journal of Medicine ...
... origin of osteogenesis imperfecta, researchers say , WEDNESDAY, Jan. ... a recessive form of brittle bone disease has been ... to be identified in a sequence of genes involved ... fatal genetic condition that weakens bones, resulting in frequent ...
... aid vaccine development, but could hinder efforts to eradicate ... -- Gorillas carry the parasite that causes malignant malaria ... to develop a vaccine for malaria, researchers say. , ... mosquitoes, most commonly in areas such as sub-Saharan Africa ...
Cached Medicine News:Health News:AXIOM Systems, Inc. Announces General Release of HIPAA 5010 Testing Solutions 2Health News:Park Avenue Podiatric Care Opens New Office in Staten Island Specializing in Cosmetic Foot Surgery 2Health News:Park Avenue Podiatric Care Opens New Office in Staten Island Specializing in Cosmetic Foot Surgery 3Health News:ChildFund Partners With Christian Blind Mission in Haiti 2Health News:ChildFund Partners With Christian Blind Mission in Haiti 3Health News:Herpes medication does not reduce risk of HIV transmission, UW-led international study finds 2Health News:Herpes medication does not reduce risk of HIV transmission, UW-led international study finds 3Health News:Herpes medication does not reduce risk of HIV transmission, UW-led international study finds 4Health News:New Gene ID'd in Brittle Bone Disease 2Health News:Malaria Parasite Infects Gorillas, Not Just Humans 2
... OmniMD Medical Billing system allows a ... accounting. It is integrated with the ... The system interfaces with electronic clearinghouses ... With a set of reports, it ...
... CPNG3 single liquid stable reagent offers ... single liquid stability to help maximize ... provide quick result turnaround time. The ... CPNG3 reagent provides a long shelf ...
... Infinity Uric Acid single liquid stable ... convenience of single liquid stability to ... error and provide quick result turnaround ... Infinity Uric Acid reagent provides a ...
... Oxidase single liquid stable reagent offers ... single liquid stability to help maximize ... provide quick result turnaround time. The ... Oxidase reagent provides a long shelf ...
Medicine Products: